Swiss Life Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$303M Sell
1,192,228
-80,313
-6% -$18.7M 1.25% 13
2026
Q1
$305M Buy
1,272,541
+143,040
+13% +$33.3M 1.49% 12
2025
Q4
$234M Sell
1,129,501
-138,908
-11% -$27.5M 1.19% 12
2025
Q3
$235M Sell
1,268,409
-26,035
-2% -$4.46M 1.22% 12
2025
Q2
$198M Buy
1,294,444
+241,500
+23% +$37.1M 1.17% 14
2025
Q1
$175M Buy
1,052,944
+85,056
+9% +$13.3M 1.27% 16
2024
Q4
$140M Buy
967,888
+466,777
+93% +$72.3M 1.03% 17
2024
Q3
$81.2M Sell
501,111
-11,918
-2% -$1.9M 0.92% 18
2024
Q2
$75M Buy
513,029
+89,301
+21% +$13.3M 0.88% 17
2024
Q1
$67M Sell
423,728
-62,236
-13% -$9.91M 0.93% 20
2023
Q4
$76.2M Buy
485,964
+94,595
+24% +$14.5M 0.92% 16
2023
Q3
$60.9M Buy
391,369
+31,229
+9% +$5.15M 0.94% 13
2023
Q2
$59.6M Sell
360,140
-35,732
-9% -$5.77M 0.88% 13
2023
Q1
$61.4M Buy
395,872
+52,714
+15% +$8.51M 0.92% 13
2022
Q4
$60.7M Sell
343,158
-13,406
-4% -$2.31M 1.01% 11
2022
Q3
$58.2M Sell
356,564
-5,787
-2% -$979K 1.01% 9
2022
Q2
$64.4M Sell
362,351
-27,475
-7% -$4.9M 1.04% 9
2022
Q1
$69M Sell
389,826
-25,381
-6% -$4.32M 0.97% 11
2021
Q4
$71M Sell
415,207
-24,419
-6% -$4M 0.92% 12
2021
Q3
$71M Sell
439,626
-6,234
-1% -$1.06M 0.98% 9
2021
Q2
$73.3M Buy
445,860
+624
+0.1% +$103K 0.74% 15
2021
Q1
$73.2M Sell
445,236
-3,308
-0.7% -$535K 1.05% 9
2020
Q4
$70.6M Sell
448,544
-95,920
-18% -$14.2M 1.03% 10
2020
Q3
$81M Sell
544,464
-27,637
-5% -$4.09M 1.2% 11
2020
Q2
$80.5M Buy
572,101
+3,108
+0.5% +$453K 1.3% 8
2020
Q1
$74.6M Buy
568,993
+118,746
+26% +$16.8M 1.42% 8
2019
Q4
$65.7M Sell
450,247
-315,771
-41% -$42.8M 1.24% 13
2019
Q3
$99.1M Sell
766,018
-38,843
-5% -$5.12M 1.29% 14
2019
Q2
$112M Buy
804,861
+18,261
+2% +$2.53M 1.35% 13
2019
Q1
$110M Buy
786,600
+104,931
+15% +$14.1M 1.39% 11
2018
Q4
$88M Sell
681,669
-82,686
-11% -$11.5M 1.79% 9
2018
Q3
$106M Buy
764,355
+52,409
+7% +$6.96M 1.42% 9
2018
Q2
$86.4M Buy
711,946
+16,820
+2% +$2.1M 1.29% 14
2018
Q1
$89.1M Buy
695,126
+216,121
+45% +$29.2M 1.56% 7
2017
Q4
$66.9M Buy
479,005
+11,568
+2% +$1.61M 1.49% 9
2017
Q3
$60.8M Buy
467,437
+12,397
+3% +$1.64M 1.63% 7
2017
Q2
$60.2M Buy
455,040
+3,164
+0.7% +$404K 1.55% 7
2017
Q1
$56.3M Sell
451,876
-27,001
-6% -$3.23M 1.52% 8
2016
Q4
$55.2M Sell
478,877
-13,963
-3% -$1.61M 1.85% 7
2016
Q3
$58.2M Sell
492,840
-6,445
-1% -$782K 1.98% 5
2016
Q2
$60.5M Buy
499,285
+41,293
+9% +$4.69M 2.49% 4
2016
Q1
$49.6M Buy
457,992
+3,836
+0.8% +$397K 2.09% 6
2015
Q4
$46.7M Buy
454,156
+6,490
+1% +$653K 2.07% 5
2015
Q3
$41.8M Buy
447,666
+79,254
+22% +$7.67M 2.03% 5
2015
Q2
$35.9M Buy
368,412
+20,281
+6% +$2.03M 1.26% 7
2015
Q1
$35M Buy
+348,131
New +$35.4M 1.41% 7

Other funds holding JNJ

Swiss Life Asset Management's JNJ Position: Q2 2026 in Review

Swiss Life Asset Management reduced its Johnson & Johnson (JNJ) stake by 6.3% in Q2 2026, selling an estimated $18.7M and leaving 1,192,228 shares worth $303M. The position accounts for 1.25% of the portfolio, ranked #13.

Swiss Life Asset Management first reported a position in JNJ in Q1 2015 and has held it in 46 quarters since. The position peaked at $305M in Q1 2026. 3,637 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Swiss Life Asset Management held 1,192,228 shares of Johnson & Johnson worth $303M as of Q2 2026.
  • Swiss Life Asset Management sold 80,313 Johnson & Johnson shares in Q2 2026, an estimated $18.7M.
  • Johnson & Johnson made up 1.25% of Swiss Life Asset Management's portfolio in Q2 2026, its #13 holding.
  • Swiss Life Asset Management first reported a position in Johnson & Johnson in Q1 2015 and has held it in 46 quarters since.
  • Swiss Life Asset Management's Johnson & Johnson position peaked at $305M in Q1 2026.
  • 3,637 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.